J. C. Brimecombe

Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern.

A. Brown, G. Kirsch, A. E. Lacerda, 2004, Journal of pharmacological and toxicological methods.

Test article concentrations in the hERG assay: losses through the perfusion, solubility and stability.

A. Brown, G. Kirsch, J. C. Brimecombe, 2009, Journal of pharmacological and toxicological methods.

An NR2B point mutation affecting haloperidol and CP101,606 sensitivity of single recombinant N-methyl-D-aspartate receptors.

D. Lynch, E. Aizenman, J. C. Brimecombe, 1998, The Journal of pharmacology and experimental therapeutics.

An NR 2 B Point Mutation Affecting Haloperidol and CP 101 , 606 Sensitivity of Single Recombinant N-Methyl-D-Aspartate Receptors 1

D. Lynch, E. Aizenman, J. C. Brimecombe, 1998 .

A critical role of the N-methyl-D-aspartate (NMDA) receptor subunit (NR) 2A in the expression of redox sensitivity of NR1/NR2A recombinant NMDA receptors.

E. Aizenman, J. C. Brimecombe, W. Potthoff, 1999, The Journal of pharmacology and experimental therapeutics.

Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors.

E. Aizenman, J. C. Brimecombe, F. Boeckman, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Functional consequences of NR 2 subunit composition in single recombinant N-methyl-D-aspartate receptors

E. Aizenman, J. C. Brimecombe, F. Boeckman, 1997 .

Why is the role of nitric oxide in NMDA receptor function and dysfunction so controversial?

P. Rosenberg, E. Aizenman, J. C. Brimecombe, 1998, Progress in brain research.

Alterations of N-methyl-D-aspartate receptor properties after chemical ischemia.

E. Aizenman, J. C. Brimecombe, G. A. Herin, 2000, The Journal of pharmacology and experimental therapeutics.